
	Where results make sense

Topic: USAMRICD

Related Topics

Oedelem

Justinus

Tursib

Toona

Gometra

Silvaco

Bernera

Caribou, California

Goias

Tarsier

Cheesemaker

Academy of Persian Language and Literature

Hymenaues

Loihi

Swatow

	USAMRICD - Wikipedia
		The U.S. Army Medical Research Institute of Chemical Defense (USAMRICD), Aberdeen Proving Ground, Maryland, is charged with the development, testing, and evaluation of medical treatments and material to prevent and treat casualties of chemical warfare agents.
		Its mission includes fundamental and applied research in the pharmacology, physiology, toxicology, pathology, and biochemistry of chemical agents and their medical countermeasures.
		The USAMRICD supports a Chemical/Biological Rapid Response Team (C/B-RRT), supports and trains Theater Army Medical Laboratory personnel, and maintains a unique chemical surety facility.
	en.wikipedia.org /wiki/USAMRICD (153 words)

	AWIC Newsletter: Reducing Animal Research at the U.S. Army Medical Research Institute of Chemical Defense
		The USAMRICD AAALAC-accredited since 1984 and with an established animal care and use committee overseeing animal research since the late 1970s was already in compliance with much of the Department of Defense directive when it was issued in 1995 and well on its way to meeting the goals of its Command's research objectives.
		Researchers at the USAMRICD use the Aplysia californica, a large naked marine mollusk or gastropod with anterior sensory tentacles, commonly referred to as the sea hare or sea slug.
		The USAMRICD acknowledges that in certain sulfur mustard experimental protocols, SKH-1 hairless mice are an appropriate substitute for the hairless guinea pig.
	www.nal.usda.gov /awic/newsletters/v8n3/8n3army.htm (1230 words)

	Biotechnology News and Information Portal, biotech jobs and career resources Resources. (Site not responding. Last check: 2007-10-14)
		Based on discussions with both USAMRICD and DRDC Suffield Nexia believes that Protexia(TM), if and when approved by regulatory authorities, may be used for prophylaxis and treatment in military markets.
		USAMRICD develops medical countermeasures to chemical warfare agents and trains medical personnel in the medical management of chemical casualties and is a recognized leader in this field.
		Except for the historical information presented herein, matters discussed herein may constitute forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.
	www.bioexchange.com /news/news_page.cfm?id=19006 (1392 words)

	Towson University Biology Graduate Program
		Research Assistants at USAMRICD receive a stipend of approximately $21,000 (depending on the amount of time spent in the laboratory), but do not receive a tuition waiver.
		Research Assistants at the USAMRICD usually spend 40 hours/week participating in thesis related research under the direction of their faculty research mentor.
		The USAMRICD laboratories are located approximately 30 minutes northeast of the Towson University campus, near the town of Aberdeen, Maryland.
	wwwnew.towson.edu /biologicalsciences/grad_assistant.html (358 words)

	Encyclopedia: USAMRIID
		Award-winning military and civilian scientists, highly trained support personnel, and unique, state-of-the-art research facilities make USAMRIID a critical resource for the Army, the Department of Defense, and the United States.
		A scientist is a person who is expert in an area of science and who uses scientific methods in research.
		USAMRICD - U.S. Army Medical Research Institute of Chemical Defense Categories: Stub...
	www.nationmaster.com /encyclopedia/USAMRIID (678 words)

	USAMRICD (Site not responding. Last check: 2007-10-14)
		USAMRICD, located at Aberdeen Proving Ground, Md., is the Department of Defense’s lead laboratory for the development of medical countermeasures against chemical warfare (CW) agents and is where personnel are trained in the medical management of chemical casualties.
		The Research Participation Program at USAMRICD is in its fourth year and has about 20 ORISE participants involved in almost all facets of the research effort at the Institute.
		She was initially assigned to USAMRICD for a summer appointment and returned to the institute as an ORISE participant from August 1998 to August 1999.
	www.orau.gov /orise/edu/rpinsights/archives/0799.htm (1577 words)

	II (Site not responding. Last check: 2007-10-14)
		One of the two visiting USAMRICD doctors told investigators that the soldier with the burning eyes and face did indeed develop a life-threatening case of pneumonia, but his injury occurred when he was inside an Iraqi tank and was splashed in the face with ammonia, which was there for cleaning the main gun.
		USAMRICD sent eight people (four doctors, three clinical scientists, and one non-commissioned officer) to provide high-level CWA medical expertise during Desert Storm.
		In these interviews the USAMRICD team members stated that they saw no indications of injuries attributable to post-war CWA use—most of the casualties the USAMRICD team saw were US or Iraqi soldiers injured during combat.
	www.gulflink.osd.mil /postwar/postwar_s02.htm (3711 words)

	MANHATTAN PHARMACEUTICALS, INC. \| PRESS RELEASES (Site not responding. Last check: 2007-10-14)
		The USAMRICD is a world leader in medical chemical defense research.
		The USAMRICD's mission is to protect the warfighter by timely provision of medical countermeasures.
		Each drug that is a candidate pretreatment, treatment, protectant, or decontaminant is subjected to a systematic battery of tests designed to promote those that are the safest and most effective to advanced development.
	www.manhattanpharma.com /pr_051701_2.html (706 words)

	PostdocJobs.com - Biochemical Pharmacology Research (Site not responding. Last check: 2007-10-14)
		USAMRICD, located in Aberdeen Proving Ground, Maryland (near Baltimore), is the Department of Defense’s lead laboratory for the execution of medical chemical defense research.
		The initial appointment is for one year and may be renewed for up to three additional years upon recommendation of USAMRICD and subject to availability of funds.
		The Research Participation Program for USAMRICD is administered by the Oak Ridge Institute for Science and Education.
	www.post-docs.com /jobs/303520.shtml (395 words)

	A Medical Research and Evaluation Facility and Studies Supporting the Medical Chemical Defense Program. Task 92-29: ...
		Abstract: The objective of this work was to determine the dose-response relationship between the duration of a topical exposure of sulfur mustard vapors to hairless guinea pigs (HGPs) and the incidence of microblisters observed histologically.
		The exposure time needed to produce a 50 percent incidence of microblisters in HGP skin exposed to saturated HD vapors was approximately 7.5 min.
		Comparison with USAMRICD study results indicated that the HGPs used in the present study were more tolerant of HD vapors by approximately 2 min.
	www.stormingmedia.us /39/3970/A397033.html (235 words)

	A Medical Research and Evaluation Facility (MREF) and Studies Supportingthe Medical Chemical Defense Program - Storming ...
		One research objective of the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) is to assess the risk of pulmonary HD exposure and to identify early markers of exposure.
		HD is a highly reactive compound that is unstable in biological fluids, making it difficult to quantify the dose received deep in the lungs after an aerosol exposure.
		As part of a USAMRICD Study, Protocol No. 1-04-97-000-A- 741, lung specimens from rats that had been intravenously exposed to HI) were sent to Battelle's Medical Research and Evaluation Facility (MREF) and assessed for activation of nuclear factor kappa B (NF-kB), a transcription factor involved in the inflammatory response.
	www.stormingmedia.us /56/5662/A566273.html (341 words)

	SIGNIFICANT RPT OF USAMRICD 19 FEB 91 (Site not responding. Last check: 2007-10-14)
		PURPOSE: Tle purpose of this report is to record activities of the forward detachment of the USAMRICD deployed to Operation Desert Storm for the period of 17 January to 15 February 1991.
		BACKGROUND: On request of the CINC, U.S. Central Command, USAMRDC deployed a cell of three officers from the USAMRICD to provide staff support and training in chemical casualty care for Operation Desert Shield from September to December 1990.
		CONCEPT OF OPERATION: Tle concept of operation approved by the Central Command Surgeon involves deployment of clinical cells with each of three Corps-level U.S. ground combat elements, and retention of a staff officer at the Central Command Surgeon's Office for conununication and coordination.
	www.gulflink.osd.mil /declassdocs/otsg/19970101/970101_sep96_decls17_0001.html (322 words)

	Army Shares Expertise in Mass Casualty Response (Site not responding. Last check: 2007-10-14)
		The HM-CBRNE Course is a joint venture of USAMRICD, the Army Medical Research Institute of Infectious Diseases (USAMRIID), and the Armed Forces Radiobiology Research Institute (AFRRI).
		HM-CBRNE is an outgrowth of the Army's premier training vehicles: the Medical Management of Chemical and Biological Casualties Course, co-taught by USAMRICD and USAMRIID, and the Medical Effects of Ionizing Radiation Course, taught by AFRRI.
		However, since instruction is focused on the civilian sector, the HM-CBRNE course covers additional subjects not included in the military-specific courses, for example, high-yield blast injuries, the national requirements and standards, and the adaptation of hospital procedures to national and local standards.
	www.armymedicine.army.mil /news/mercury/05-06/masscasualty.cfm (508 words)

	USAMRIID (Site not responding. Last check: 2007-10-14)
		The organization's role in Ebola-Reston outbreak of 1989 was the focus of Richard Preston's 1994 book The Hot Zone (ISBN 0385479565).
		USAMRICD - U.S. Army Medical Research Institute Chemical Defense
		The Medical Management of Biological Casualties Handbook, issued by the U.S. Army Medical Research Institute of Infectious Diseases at Fort Detrick (Maryland), is a concise guidebook distributed to military medical personnel for use out in the field.
	www.freeglossary.com /U.S._Army_Medical_Research_Institute_of_Infectious_Diseases (215 words)

	Nexia's Military Biotech Drug Protexia(R) Shows Promise as a Rescue Therapy for Civilian CW Casualties
		The risk of VX to humans is predominantly via skin or surface exposure; therefore, both military organizations' teams focused their trials on skin factors.
		Experimental Results Prove Efficacy USAMRICD administered Protexia(R) intramuscularly to guinea pigs approximately an hour after they had been exposed to 2X or 5X lethal doses of VX on the skin.
		About USAMRICD The U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) develops medical countermeasures to chemical warfare agents and trains medical personnel in the medical management of chemical casualties and is a recognized leader in this field.
	www.prnewswire.com /cgi-bin/stories.pl?ACCT=109&STORY=/www/story/12-14-2004/0002630882&EDATE= (1454 words)

	StockJunction.com - Nexia Biotechnologies Inc ( NXB )
		Blood-derived BChE is currently being developed by the USAMRICD for use by military personnel to prevent the toxic effects of nerve agents.
		It is a biopharmaceutical protein where transgenics may provide a significant supply advantage, it fits with our other military initiatives, and its development will likely be rapid and significantly accretive to shareholder value,'commented Jeffrey D. Turner, Ph.D., President and CEO of Nexia.
		Based on discussions with both USAMRICD and DRDC-Suffield Nexia believes that Protexia(TM), if and when licenced by regulatory authorities, may be used for prophylaxis and treatment in military markets.
	www.stockjunction.com /modules.php?name=News&file=print&sid=722 (834 words)

	NINDS Counterterrorism and Neuroscience Workshop: National Institute of Neurological Disorders and Stroke (NINDS)
		The NIH, with its mission to improve the health of the Nation by conducting and supporting biomedical research, is taking a leadership role in pursuing the development of new and improved medical countermeasures designed to prevent, diagnose, and treat the conditions caused by potential agents of terrorism.
		However, USAMRICD has historically focused on developing chemical agent countermeasures to be used in the context of traditional warfare, and there are significant differences between traditional warfare and terrorism that must be considered in developing effective countermeasures:
		The vaccinia virus, the active component of the smallpox vaccine, is associated with a rare incidence of encephalitis.
	www.ninds.nih.gov /news_and_events/proceedings/counterterrorismworkshop2004.htm (1973 words)

	Chem-Bio.com Resource Center
		USAMRICD - Chemical Casualty Care Division - Triage Case Studies (PowerPoint - ZIP - 22K)
		USAMRICD - Chemical Casualty Care Division - Vesicants (PowerPoint - ZIP - 38K)
		USAMRICD - Chemical Casualty Care Division - Casualty Decon Layout (PowerPoint - ZIP - 14K)
	www.chem-bio.com /resource (2625 words)

	RESECO (Site not responding. Last check: 2007-10-14)
		RESECO is currently providing advanced discipline services in biomedical engineering disciplines to USAMRICD under subcontract to a NASA SEWP II vendor, through which ICD has purchased his services.
		Serving as and advanced discipline specialist on DAKKRO’s contracts with USAMRICD (1985 to 1998), he managed numerous contract tasks -- leading a team which provided support in the areas of custom applications programming; hardware and software engineering; laboratory engineering; molecular modeling; statistical theory; and database administration services.
		For the commercial sector, he has developed systems to measure and analyze properties of thin films (Electroimpedance Spectroscopy); to perform automated digital image processing (cell morphometry); to control (using embedded software) a commercial blood pressure instrument; and to track usage of periodicals in libraries using bar code technology.
	www.users.interport.net /r/e/reseco (1229 words)

	Transition and Use of the Mouse Ear Model for Evaluating Candidate Pre- and Post-Treatrnents for Efficacy Against ...
		Abstract: The mouse ear model has been used at the U.S. Army Medical Institute of chemical Defense (USAMRICD) to assess dermal injury caused by sulfur mustard (HD) and to evaluate potential pre- and posttreatment compounds for efficacy against percutaneous HD injury.
		In this model, the effects of HD with or without treatment compounds are evaluated macroscopically by edema and microscopically by histopathological changes associated with HD injury.
		The MREF has evaluated 334 candidate HD treatment compounds provided by USAMRICD, and 73 passed the initial screening.
	www.stormingmedia.us /70/7007/A700773.html (267 words)

	StockJunction.com - Nexia Biotechnologies Inc ( NXB )
		Nexia Biotechnologies Inc. (TSX: NXB) reported today that the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) presented results from its Protexia(TM) program at the Joint Services Scientific Conference on Chemical and Biological Defense in Towson, Maryland.
		Nexia continues to collaborate with both the USAMRICD and Defence R&D Canada Suffield (DRDC Suffield) to test Protexia(TM) in both in vitro and in vivo model systems.
		We believe our transgenics technology provides a significant supply advantage,'comments Jeffrey D. Turner, President and CEO of Nexia Biotechnologies Inc. 'Our partnership with USAMRICD will allow Nexia to build on their considerable experience and advance together in the area of medical countermeasures.'
	www.stockjunction.com /modules.php?name=News&file=print&sid=1656 (934 words)

	USAMRIID - Education
		These programs provide detailed information for military and civilian medical and public health professionals in the recognition and management of biological and chemical casualties, and in notifying the appropriate response agencies.
		The target audience is military and civilian medical care providers, public health professionals, clinical laboratory staff, first responders, and others who would assist in recognizing and managing casualties from a biological or chemical agent attack.
		Our sister unit, USAMRICD, CCCD will provide the tapes of the bio/chem program to requesting DoD medical organizations.
	www.usamriid.army.mil /education/satellite.htm (620 words)

	FDA Chapter, Sigma Xi - Officer's Biographies
		Yourick received his undergraduate degree in biology from Kalamazoo College, a master's degree in biological sciences from Western Michigan University and his PhD in pharmacology and toxicology from the University of Kansas.
		Yourick was a research pharmacologist at the US Army Medical Research Institute of Chemical Defense (USAMRICD) before joining the FDA in 1993.
		He was inducted into Sigma Xi from the USAMRICD in 1989.
	vm.cfsan.fda.gov /~frf/sxbios.html (702 words)

	Army shares expertise in mass casualty response (Site not responding. Last check: 2007-10-14)
		The course is a joint venture of USAMRICD, the Army Medical Research Institute of Infectious Diseases, and the Armed Forces Radiobiology Research Institute.
		However, since instruction is focused on the civilian sector, the HM-CBRNE course covers subjects not included in the military-specific courses, like high-yield blast injuries, the national requirements and standards, and the adaptation of hospital procedures to national and local standards.
		More information about the course is available from the Chemical Casualty Care Division, USAMRICD, at DSN 584-2230/3393 or (410) 436-2230/3393, by electronic mail at ccc@apg.amedd.army.mil, or by writing to Commander, USAMRICD, Attn: MCMR-UV-ZM (Chemical Casualty Care Division), 3100 Ricketts Point Road, Aberdeen Proving Ground, MD 21010-5400).
	www.dcmilitary.com /army/stripe/10_27/national_news/35841-1.html (507 words)

	Current Issue - Speeches & Testimony (Site not responding. Last check: 2007-10-14)
		In this portion of DeploymentLINK, you will find transcripts or media coverage of important speeches or congressional testimony by government and military officials related to military deployments or health.
		Dr. Sheridan provided a briefing on USAMRICD research on Low-Level Chemical Warfare Agent Exposure: Effects and Countermeasures.
		October 16, 2003, Edward P. Wyatt, Jr., Principal Deputy Assistant Secretary of Defense (Health Affairs) gave a Prepared Statement on The Transition of Service Members Requiring Health Care Between the Department of Defense and the Department of Veterans Affairs Before the Committee on Veterans' Affairs, U.S. House of Representatives.
	deploymentlink.osd.mil /current_issues/speech_test/testimony_2003.shtml (633 words)

	Lienmarché CNX (Site not responding. Last check: 2007-10-14)
		Protexia(TM) Program Update Nexia is developing a recombinant version of human butyrylcholinesterase (Protexia(TM)), a bioscavenger, as a medical countermeasure for nerve agents.
		Three key milestones have been targeted within the next 12 months: - First, to demonstrate in vitro binding and neutralization by Protexia(TM) of a variety of nerve agents, including soman, sarin, VX and tabun.
		About USAMRICD USAMRICD develops medical countermeasures to chemical warfare agents and trains medical personnel in the medical management of chemical casualties and is a recognized leader in this field.
	www.cnxmarketlink.com /fr/releases/archive/November2003/20/c4450.html (892 words)

	Appendix E TECHNICAL REACH-BACK CAPABILITIES Cont. (Site not responding. Last check: 2007-10-14)
		The USAMRICD provides medical and scientific SMEs and technical guidance to
		USAMRICD can provide technical guidance for assessing and evaluating a chemical
		See Appendix D for additional information on the USAMRICD’s capabilities.
	www.tpub.com /content/USMC/mcr3372c/css/mcr3372c_121.htm (328 words)

	NBC
		The US Army Medical Research Institute of Infectious Diseases (USAMRIID) and the US Army Medical Research Institute of Chemical Defense (USAMRICD) jointly conduct the Medical Management of Chemical and Biological Casualties Course.
		The course is designed for Medical Corps and Nurse Corps officers, physician assistants, Medical Service Corps officers in specialties 67B,C, or E, and other selected medical professionals.
		For more information, contact the Chemical Casualty Care Division, USAMRICD at DSN 584-2230/3393, CML (410) 436-2230/3393, DSN FAX 584-3086, CML (410) 436-3086, e-mail: ccc@apg.amedd.army.mil, or write to: Commander, USAMRICD, ATTN: MCMR-UV-ZM (Chemical Casualty Care Division), 3100 Ricketts Point Road, Aberdeen Proving Ground, MD 21010-5400.
	www.medtrng.com /nbc.html (326 words)

Try your search on: Qwika (all wikis)